JPH0551613B2 - - Google Patents
Info
- Publication number
- JPH0551613B2 JPH0551613B2 JP61116254A JP11625486A JPH0551613B2 JP H0551613 B2 JPH0551613 B2 JP H0551613B2 JP 61116254 A JP61116254 A JP 61116254A JP 11625486 A JP11625486 A JP 11625486A JP H0551613 B2 JPH0551613 B2 JP H0551613B2
- Authority
- JP
- Japan
- Prior art keywords
- hpd
- solution
- polymer
- dissolved
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920000642 polymer Polymers 0.000 claims description 20
- 150000004032 porphyrins Chemical class 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 125000005647 linker group Chemical group 0.000 claims description 2
- 230000000379 polymerizing effect Effects 0.000 claims description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 12
- 206010028980 Neoplasm Diseases 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000003504 photosensitizing agent Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 229910001873 dinitrogen Inorganic materials 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- UJKPHYRXOLRVJJ-MLSVHJFASA-N CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C Chemical compound CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C UJKPHYRXOLRVJJ-MLSVHJFASA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 229960003569 hematoporphyrin Drugs 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 1
- 238000004435 EPR spectroscopy Methods 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002601 intratumoral effect Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 229950003776 protoporphyrin Drugs 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polyethers (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61116254A JPS6263586A (ja) | 1986-05-22 | 1986-05-22 | ポルフイリンポリマ− |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61116254A JPS6263586A (ja) | 1986-05-22 | 1986-05-22 | ポルフイリンポリマ− |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60085439A Division JPS61246232A (ja) | 1985-04-23 | 1985-04-23 | ポルフィリンポリマーの製造法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6263586A JPS6263586A (ja) | 1987-03-20 |
JPH0551613B2 true JPH0551613B2 (enrdf_load_stackoverflow) | 1993-08-03 |
Family
ID=14682568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61116254A Granted JPS6263586A (ja) | 1986-05-22 | 1986-05-22 | ポルフイリンポリマ− |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6263586A (enrdf_load_stackoverflow) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5079262A (en) * | 1989-07-28 | 1992-01-07 | Queen's University At Kingston | Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid |
US5234940A (en) * | 1989-07-28 | 1993-08-10 | Queen's University | Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof |
US5252730A (en) * | 1992-04-10 | 1993-10-12 | Northrop Corporation | Polymer composition having intense magnetic properties and method for preparation thereof |
US5493017A (en) * | 1992-08-14 | 1996-02-20 | The Trustees Of The University Of Pennsylvania | Ring-metalated porphyrins |
-
1986
- 1986-05-22 JP JP61116254A patent/JPS6263586A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS6263586A (ja) | 1987-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69526782T2 (de) | Texaphyrin metallkomplexe mit verbesserten funktionellen gruppen | |
DE68914457T2 (de) | Gereinigte hematoporphyrin trimere zur verwendung bei photodynamischer therapie. | |
CN100381444C (zh) | 酞菁硅配合物及其复合物以及它们的制备和应用 | |
EP0120054B1 (en) | Purified hematoporphyrin derivative for diagnosis and treatment of tumors, and method | |
DE69922216T2 (de) | Porphyrin derivate, ihre verwendung in der photodynamischen therapie und diese enthaltende medizinische geräte | |
DK167769B1 (da) | Fluorescerende mono-, di- eller polyamider af en aminodicarboxylsyre og en tetrapyrrolforbindelse indeholdende tre carboxylgrupper samt fremgangsmaade til fremstilling deraf | |
CA2268968C (en) | Iminochlorin aspartic acid derivatives | |
EP1066293B1 (de) | Porphyrine und ihre verwendung als photosensitizer | |
CN104844645B (zh) | 一种轴向ala修饰的硅酞菁及其制备方法和应用 | |
DE69913351T2 (de) | Metallkomplexe von Chlorinderivaten zum Abschirmen von Röntgenstrahlen | |
JP5290142B2 (ja) | 新規な糖連結クロリン誘導体 | |
JPH0551613B2 (enrdf_load_stackoverflow) | ||
JPH0554489B2 (enrdf_load_stackoverflow) | ||
KR100748908B1 (ko) | 포르피린 화합물 | |
JPS62249986A (ja) | ポルフイリン誘導体 | |
EP2072584A1 (de) | Phthalocyanin-Farbstoffe, ihre Herstellung und Verwendung | |
JP3718887B2 (ja) | ポルフィリン誘導体とその用途 | |
JPH01250381A (ja) | フェオフォルバイド誘導体 | |
CN113717183B (zh) | 周环不对称精氨酸修饰酞菁及其制备和在制药领域的应用 | |
CN118221711A (zh) | 一种bodipy二聚体荧光探针及其制备方法和应用 | |
JPS62182663A (ja) | 放射性金属標識癌診断剤 | |
KR101620577B1 (ko) | 클로린 유도체를 함유하는 여드름 치료제 및 피지분비 억제제, 및 이를 포함하는 광역학적 치료용 키트 | |
JPS63145283A (ja) | ポルフイリン誘導体 | |
JPS61186385A (ja) | デユウテロポルフイリン誘導体及びその塩 | |
JPS63154689A (ja) | 修飾ポルフイリンおよび抗腫瘍剤 |